New 3D Structures of Cannabinoid Receptor Inform Safer Drug Design

PT344 – Susan Beaulieu – Epigenetics, Resilience, and Remembering

MindMed Board of Directors Approves Reverse Share Split

COMPASS Pathways plc announces second quarter 2022 financial results and business...

MindMed to Participate in the Canaccord Genuity 42nd Annual Growth Conference

Canadian Patent Grant Strengthens Small Pharma’s International Position

Algernon Pharmaceuticals Invited to Present Phase 2 IPF and Chronic Cough...

Braxia Scientific Enters U.S. Telemedicine Industry; Acquires KetaMD, a Mental Health...

Incannex Engages Curia to Scale-up Manufacture of cGMP IHL-216A

Opening the Mushroom Pharmacopeia: The Case of Norbaeocystin

Load more